Next Article in Journal
Development of Quorum-Based Anti-Virulence Therapeutics Targeting Gram-Negative Bacterial Pathogens
Previous Article in Journal
Mechanisms of Lin28-Mediated miRNA and mRNA Regulation—A Structural and Functional Perspective
Int. J. Mol. Sci. 2013, 14(8), 16554-16569; doi:10.3390/ijms140816554
Article

Skp2 Regulates Subcellular Localization of PPARγ by MEK Signaling Pathways in Human Breast Cancer

1,†
, 1,†
, 1,†
, 1
, 1
, 1
, 1
, 1
, 2
, 3,*  and 1,*
Received: 20 March 2013; in revised form: 15 July 2013 / Accepted: 19 July 2013 / Published: 9 August 2013
(This article belongs to the Section Molecular Pathology)
View Full-Text   |   Download PDF [1754 KB, uploaded 19 June 2014]   |   Browse Figures
Abstract: Nuclear hormone receptor family member PPARγ plays an important role in mammary gland tumorigenesis. Previous studies have shown PPARγ has cytoplasmic activities upon tetradecanoyl phorbol acetate (TPA) stimulation. However, the clinical pathological significance of cytoplasmic PPARγ is not completely understood in human breast cancer. Skp2 is oncogenic, and its frequent amplification and overexpression correlated with the grade of malignancy. In this study, the role of cytoplasmic PPARγ and Skp2 expression was investigated in human breast cancer progression. Therefore, immunohistochemical analysis was performed on formalin-fixed paraffin sections of 70 specimens. Furthermore, Western blot and immunofluorescence microscopy analysis were used to study the relationship between expression of cytoplasmic PPARγ and Skp2 expression in human breast cancer cells in vitro. Results showed that the expression of cytoplasmic PPARγ was positively correlated with Skp2 expression (p < 0.05), and correlated significantly with estrogen receptor (p = 0.026) and pathological grade (p = 0.029), respectively. In addition, Skp2 overexpression can provoke cytoplasmic localization of PPARγ upon MEK1-dependent mechanisms in human breast cancer cells by nuclear-cytosolic fractionation technology and immunofluorescence microscopy analysis. Using RNA interference technology, we also found that down-regulated Skp2 reduced the phosphorylation level of MEK1 and significantly reversed TPA-induced nuclear export of PPARγ in MDA-MB-231 cells. The changes in the subcellular localization of PPARγ may represent a novel target for selective interference in patients with breast cancer.
Keywords: cytoplasmic localization; peroxisome proliferator-activated receptors γ (PPARγ); S-phase kinase protein (Skp2); human breast cancer cytoplasmic localization; peroxisome proliferator-activated receptors γ (PPARγ); S-phase kinase protein (Skp2); human breast cancer
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Cheng, H.; Meng, J.; Wang, G.; Meng, Y.; Li, Y.; Wei, D.; Fu, C.; Deng, K.; Shen, A.; Wang, H.; Dai, S. Skp2 Regulates Subcellular Localization of PPARγ by MEK Signaling Pathways in Human Breast Cancer. Int. J. Mol. Sci. 2013, 14, 16554-16569.

AMA Style

Cheng H, Meng J, Wang G, Meng Y, Li Y, Wei D, Fu C, Deng K, Shen A, Wang H, Dai S. Skp2 Regulates Subcellular Localization of PPARγ by MEK Signaling Pathways in Human Breast Cancer. International Journal of Molecular Sciences. 2013; 14(8):16554-16569.

Chicago/Turabian Style

Cheng, Hongge; Meng, Jie; Wang, Guisheng; Meng, Yuming; Li, Yu; Wei, Dong; Fu, Chunyun; Deng, Kaifeng; Shen, Aiguo; Wang, Huimin; Dai, Shengming. 2013. "Skp2 Regulates Subcellular Localization of PPARγ by MEK Signaling Pathways in Human Breast Cancer." Int. J. Mol. Sci. 14, no. 8: 16554-16569.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert